Cargando…
Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
BACKGROUND: Thymic stromal Lymphopoeitin (TSLP) is a key cytokine involved in inflammation and cancer progression. TSLP gene polymorphisms have been associated with increased susceptibility to cancer progression in different organs. We performed a control case study to examine the correlation of exp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687655/ https://www.ncbi.nlm.nih.gov/pubmed/31210014 http://dx.doi.org/10.1002/mgg3.813 |
_version_ | 1783442749670817792 |
---|---|
author | Semlali, Abdelhabib Almutairi, Mikhlid Reddy Parine, Narasimha Al Amri, Abdullah Almeer, Rafa Alanazi, Mohammad S. Rouabhia, Mahmoud |
author_facet | Semlali, Abdelhabib Almutairi, Mikhlid Reddy Parine, Narasimha Al Amri, Abdullah Almeer, Rafa Alanazi, Mohammad S. Rouabhia, Mahmoud |
author_sort | Semlali, Abdelhabib |
collection | PubMed |
description | BACKGROUND: Thymic stromal Lymphopoeitin (TSLP) is a key cytokine involved in inflammation and cancer progression. TSLP gene polymorphisms have been associated with increased susceptibility to cancer progression in different organs. We performed a control case study to examine the correlation of expression and polymorphisms of three nucleotides in TSLP with breast cancer (BC) risk in Saudi Arabian females. MATERIALS AND METHODS: The study was conducted on 116 healthy control subjects and 127 female patients with BC for the purpose of genotyping. Ten matching tissues provided data on immunohistochemistry to evaluate TSLP expression. Three SNPs (rs10043985, rs2289276, and rs3806933) were genotyped with TaqMan allelic discrimination assay. The patients' ages and estrogen receptor statuses were used to investigate the potential correlations between the different variations of TSLP genotypes and BC risk. RESULTS: BC tissues expressed positive immuno‐staining for TSLP at a high rate compared to normal matching breast tissues. Malignant breast tumors exhibited higher TSLP expression than benign breast tumors. We also found that the rs3806933 (T) allele frequency decreased the risk of developing BC in the study population (OR = 0.356, p = 0.00027) significantly (0.356 times). Interestingly, statistical analysis revealed that the genotype mutant (AC) and the allele mutant (C) of rs10043985 within TSLP were significantly correlated with an increased BC risk (odds ratio [OR] = 4.762, confidence interval [CI] = 1.000–22.666, p = 0.03244; OR = 4.762, CI = 1.000–22.666, p = 0.03244; and OR = 4.575, CI = 0.975–21.464, p = 0.03516, respectively). In addition, the AC and AC + CC genotypes of TSLP rs10043985 were confirmed to be associated with an increased risk of BC risk in women aged above 48 years, compared with the AA genotype (AC and AC + CC vs. AA: OR = 9.468, CI = 0.493–181.768, p = 0.04537). CONCLUSION: The results reveal significant correlation between SNPs in TSLP and BC progression in Saudi Arabian female patients. |
format | Online Article Text |
id | pubmed-6687655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66876552019-08-14 Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk Semlali, Abdelhabib Almutairi, Mikhlid Reddy Parine, Narasimha Al Amri, Abdullah Almeer, Rafa Alanazi, Mohammad S. Rouabhia, Mahmoud Mol Genet Genomic Med Original Articles BACKGROUND: Thymic stromal Lymphopoeitin (TSLP) is a key cytokine involved in inflammation and cancer progression. TSLP gene polymorphisms have been associated with increased susceptibility to cancer progression in different organs. We performed a control case study to examine the correlation of expression and polymorphisms of three nucleotides in TSLP with breast cancer (BC) risk in Saudi Arabian females. MATERIALS AND METHODS: The study was conducted on 116 healthy control subjects and 127 female patients with BC for the purpose of genotyping. Ten matching tissues provided data on immunohistochemistry to evaluate TSLP expression. Three SNPs (rs10043985, rs2289276, and rs3806933) were genotyped with TaqMan allelic discrimination assay. The patients' ages and estrogen receptor statuses were used to investigate the potential correlations between the different variations of TSLP genotypes and BC risk. RESULTS: BC tissues expressed positive immuno‐staining for TSLP at a high rate compared to normal matching breast tissues. Malignant breast tumors exhibited higher TSLP expression than benign breast tumors. We also found that the rs3806933 (T) allele frequency decreased the risk of developing BC in the study population (OR = 0.356, p = 0.00027) significantly (0.356 times). Interestingly, statistical analysis revealed that the genotype mutant (AC) and the allele mutant (C) of rs10043985 within TSLP were significantly correlated with an increased BC risk (odds ratio [OR] = 4.762, confidence interval [CI] = 1.000–22.666, p = 0.03244; OR = 4.762, CI = 1.000–22.666, p = 0.03244; and OR = 4.575, CI = 0.975–21.464, p = 0.03516, respectively). In addition, the AC and AC + CC genotypes of TSLP rs10043985 were confirmed to be associated with an increased risk of BC risk in women aged above 48 years, compared with the AA genotype (AC and AC + CC vs. AA: OR = 9.468, CI = 0.493–181.768, p = 0.04537). CONCLUSION: The results reveal significant correlation between SNPs in TSLP and BC progression in Saudi Arabian female patients. John Wiley and Sons Inc. 2019-06-17 /pmc/articles/PMC6687655/ /pubmed/31210014 http://dx.doi.org/10.1002/mgg3.813 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Semlali, Abdelhabib Almutairi, Mikhlid Reddy Parine, Narasimha Al Amri, Abdullah Almeer, Rafa Alanazi, Mohammad S. Rouabhia, Mahmoud Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk |
title | Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk |
title_full | Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk |
title_fullStr | Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk |
title_full_unstemmed | Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk |
title_short | Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk |
title_sort | expression and allele frequencies of thymic stromal lymphopoietin are a key factor of breast cancer risk |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687655/ https://www.ncbi.nlm.nih.gov/pubmed/31210014 http://dx.doi.org/10.1002/mgg3.813 |
work_keys_str_mv | AT semlaliabdelhabib expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk AT almutairimikhlid expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk AT reddyparinenarasimha expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk AT alamriabdullah expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk AT almeerrafa expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk AT alanazimohammads expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk AT rouabhiamahmoud expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk |